SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 691.75 |
| Enterprise Value ($M) | 551.66 |
| Book Value ($M) | 407.93 |
| Book Value / Share | 1.70 |
| Price / Book | 1.70 |
| NCAV ($M) | 191.55 |
| NCAV / Share | 0.80 |
| Price / NCAV | 3.61 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.09 |
| Return on Assets (ROA) | 0.09 |
| Return on Equity (ROE) | 0.17 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 9.33 |
| Current Ratio | 9.33 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 386.26 |
| Assets | 602.63 |
| Liabilities | 194.70 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 4.83 |
| Operating Income | -135.87 |
| Net Income | 53.51 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -134.37 |
| Cash from Investing | 240.89 |
| Cash from Financing | -16.96 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Citigroup Inc | 4.50 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| PROCF – Procaps Group S.A. | PRRUF – Immutep Limited |
| PRTT – Protect Pharmaceutical Corporation | PTNT – Palatin Technologies, Inc. |
| PTPI – Petros Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io